摘要
背景:瘦蛋白和胰岛素抵抗在非酒精性脂肪肝(NAFLD)的发病机制中起着重要的作用,越来越多的基因与NAFLD的发病风险有关。 目的:探讨瘦素受体(Lepr)基因多态性(q223r和k109r)与非酒精性脂肪肝(NAFLD)风险之间的遗传关系。 方法:利用PubMed, Web of Science, the Cochrane Library databases, 中国知网 (CNKI) and EMBASE数据库进行检索和整理,用95%置信区间的组合优势比(OR)对遗传关联进行评估。 结果:共对1711例NAFLD患者和1732例健康对照者进行了病例对照研究,在东南亚组等位基因模型中,k109r与NAFLD呈显著正相关(p=0.01,或=0.59,95%Ci[0.39~0.90]),而在中国亚组(p=0.24,或=1.10,95%Ci[0.94~1.29])则无显着性差异(P>0.05)。Q223 R在等位基因和隐性模型中均与NAFLD显著相关(等位基因模型:P<0.001,OR=0.57,95% CI[0.50-0.65);隐性模型:P=0.001,OR=0.67,95% CI [0.2-0.85 ]。亚组分析显示,亚裔人群中Q223和NAFLD在等位基因模型中无显著相关性(P=0.07,OR=0.67,95% CI [52-0.855]。 结论:Lepr k10 9r可能是东南亚人群NAFLD的易感因素,Lepr q2 2 3r可能是中国人群NAFLD的易感因素。
关键词: 瘦素受体,非酒精性脂肪肝,Meta分析,代谢综合征(MS)。
Current Molecular Medicine
Title:The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis
Volume: 18 Issue: 2
关键词: 瘦素受体,非酒精性脂肪肝,Meta分析,代谢综合征(MS)。
摘要: Background: Leptin and insulin resistance have been pointed out to play a role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Increasing genes were shown to be associated with the risk of NAFLD.
Objective: The study aimed to investigate the genetic association between two leptin receptor (LEPR) polymorphisms (Q223R and K109R) and the NAFLD risk.
Methods: Studies were retrieved and included by using PubMed, Web of Science, the Cochrane Library databases, Chinese National Knowledge Infrastructure (CNKI) and EMBASE database. Genetic associations were assessed with pooled odds ratios (ORs) with 95% confidence intervals (CIs).
Results: Five case-control studies with 1711 NAFLD patients and 1732 healthy controls were included in this meta-analysis. The K109R was significantly associated with NAFLD in allelic model in Southeast Asian subgroup (p=0.01, OR=0.59, 95% CI [0.39- 0.90]), but not in Chinese subgroup (p=0.24, OR=1.10, 95% CI [0.94-1.29]). The Q223R was significantly associated with NAFLD in both allelic and recessive models (allelic model: p<0.001, OR=0.57, 95% CI [0.50-0.65]; recessive model: p=0.001, OR=0.67, 95% CI [0.52-0.85]). However, subgroup analysis showed that the significant association between Q223R and NAFLD in allelic model cannot be found in Southeast Asians subgroup (p=0.07, OR=0.67, 95% CI [0.52-0.85]).
Conclusion: LEPR K109R might be a susceptible factor for NAFLD in Southeast Asian population. And LEPR Q223R might be a susceptible factor for NAFLD in Chinese population.
Export Options
About this article
Cite this article as:
The LEPR K109R and Q223R Might Contribute to the Risk of NAFLD: A Meta-Analysis, Current Molecular Medicine 2018; 18 (2) . https://dx.doi.org/10.2174/1566524018666180705110412
DOI https://dx.doi.org/10.2174/1566524018666180705110412 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monitoring of Energy Metabolism by Organic Acid Profiling Analysis in Plasma of Type 2 Diabetic Mice
Current Metabolomics and Systems Biology (Discontinued) A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Novel Approach to Treat Insulin Resistance, Type 2 Diabetes, and the Metabolic Syndrome: Simultaneous Activation of PPARα, PPARγ, and PPARδ
Current Diabetes Reviews Effectiveness of Passion Fruit Peel Flour (Passiflora edulis L.) versus Turmeric Flour (Curcuma longa L.) on Glycemic Control: Systematic Review and Meta-Analysis
Current Diabetes Reviews Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Current Pharmaceutical Design Multiple Defects in Energy Metabolism in Alzheimers Disease
Current Drug Targets Current Research Issues in the Pharmacokinetics of Antiretroviral Drugs in Children
Current Pediatric Reviews Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders
CNS & Neurological Disorders - Drug Targets A New Bone Marrow Transplantation Method for the Prevention of Graft- Versus-Host Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Neuroendocrine Mechanisms Involved in Male Sexual and Emotional Behavior
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuronal Regulators and Vascular Dysfunction in Raynauds Phenomenon and Systemic Sclerosis
Current Vascular Pharmacology Physical Exercise for the Treatment of Neuropsychiatric Disturbances in Alzheimer’s Dementia: Possible Mechanisms, Current Evidence and Future Directions
Current Alzheimer Research Potential of Flavonoids as Anti-inflammatory Agents: Modulation of Pro- Inflammatory Gene Expression and Signal Transduction Pathways
Current Drug Metabolism Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Patent Selections
Recent Patents on Medical Imaging Opioid and Cannabinoid System in Food Intake
Current Pharmaceutical Design Pathophysiological Implications of Dipeptidyl Peptidases
Current Protein & Peptide Science MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Incretins and Lipid Metabolism
Current Medicinal Chemistry